An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

Clinical trial NCT07020819 · RECRUITING

Trial details

NCT number: NCT07020819
Sponsor: Annexon, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Guillain-Barre Syndrome

Start date: 2025-09-12
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.